Parsons, C. M. http://orcid.org/0000-0003-3486-8353
Dennison, E. M. http://orcid.org/0000-0002-3048-4961
Fuggle, N. http://orcid.org/0000-0001-5463-2255
Breasail, M. Ó. http://orcid.org/0000-0002-9695-6378
Deere, K. http://orcid.org/0000-0002-9467-0798
Hannam, K.
Tobias, J. H. http://orcid.org/0000-0002-7475-3932
Cooper, C. http://orcid.org/0000-0003-3510-0709
Ward, K. A. http://orcid.org/0000-0001-7034-6750
Article History
Received: 25 August 2021
Accepted: 25 January 2022
First Online: 25 February 2022
Declarations
:
: The authors C Parsons, J Tobias, K Deere, K Ward. Outside of this work N Fuggle reports travel bursaries from Pfizer and Eli Lilly. Outside of this work E Dennison reports personal fees from Pfzier, UCB, Lilly and Viatris. Outside of this work C Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB.
: Ethical approval was granted from the Hertfordshire Research Ethics Committee (REC 10/H0311/59 and 11/EE/0196), and all participants gave written informed consent in accordance with the Declaration of Helsinki.